For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260109:nRSI2479Oa&default-theme=true
RNS Number : 2479O CVS Group plc 09 January 2026
09 January 2026
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 08 January 2026 it purchased the following number of its
ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 08/01/2026
Aggregate number of Ordinary Shares purchased: 30,898
Lowest price paid per share (GBp): 1,298.00
Highest price paid per share (GBp): 1,326.00
Volume weighted average price paid per share (GBp): 1,310.61
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,581,631 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,581,631 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 1,159,152 Ordinary Shares in aggregate at a weighted average price
of 1,228.99 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
66 1322 08/01/2026 08:01:00 1366925565233512 XLON
216 1322 08/01/2026 08:06:18 1366925565234731 XLON
304 1322 08/01/2026 08:06:18 1366925565234744 XLON
1322 1326 08/01/2026 08:12:58 1366925565235644 XLON
625 1326 08/01/2026 08:12:58 1366925565235651 XLON
277 1324 08/01/2026 08:17:17 1366925565236330 XLON
139 1322 08/01/2026 08:29:47 1366925565238411 XLON
99 1320 08/01/2026 08:29:47 1366925565238415 XLON
290 1320 08/01/2026 08:29:47 1366925565238414 XLON
550 1320 08/01/2026 08:31:19 1366925565238691 XLON
962 1318 08/01/2026 08:38:04 1366925565239624 XLON
66 1320 08/01/2026 08:38:09 1366925565239658 XLON
1104 1318 08/01/2026 08:40:03 1366925565239903 XLON
290 1318 08/01/2026 08:40:03 1366925565239905 XLON
20 1318 08/01/2026 08:40:03 1366925565239906 XLON
796 1318 08/01/2026 08:40:03 1366925565239907 XLON
1050 1318 08/01/2026 08:40:44 1366925565240010 XLON
290 1318 08/01/2026 08:40:45 1366925565240011 XLON
805 1318 08/01/2026 08:40:45 1366925565240012 XLON
122 1318 08/01/2026 08:41:08 1366925565240077 XLON
915 1316 08/01/2026 08:49:00 1366925565240863 XLON
327 1316 08/01/2026 08:49:00 1366925565240865 XLON
397 1310 08/01/2026 08:56:44 1366925565241742 XLON
334 1310 08/01/2026 08:56:44 1366925565241745 XLON
425 1310 08/01/2026 09:20:29 1366925565245248 XLON
1 1310 08/01/2026 09:20:29 1366925565245249 XLON
73 1310 08/01/2026 09:20:30 1366925565245256 XLON
66 1310 08/01/2026 09:20:36 1366925565245278 XLON
136 1308 08/01/2026 09:25:52 1366925565245718 XLON
995 1308 08/01/2026 09:25:52 1366925565245721 XLON
974 1306 08/01/2026 09:26:20 1366925565245806 XLON
964 1306 08/01/2026 09:26:20 1366925565245809 XLON
961 1304 08/01/2026 09:27:00 1366925565245903 XLON
103 1304 08/01/2026 09:27:10 1366925565245960 XLON
202 1306 08/01/2026 09:28:58 1366925565246136 XLON
440 1306 08/01/2026 09:28:58 1366925565246137 XLON
116 1308 08/01/2026 09:33:03 1366925565246664 XLON
263 1306 08/01/2026 09:34:18 1366925565246827 XLON
928 1306 08/01/2026 09:34:56 1366925565246848 XLON
914 1308 08/01/2026 09:39:15 1366925565247201 XLON
255 1308 08/01/2026 09:39:15 1366925565247202 XLON
282 1308 08/01/2026 09:39:15 1366925565247203 XLON
213 1306 08/01/2026 09:39:23 1366925565247223 XLON
1 1304 08/01/2026 09:43:25 1366925565247748 XLON
37 1304 08/01/2026 09:43:25 1366925565247749 XLON
1 1304 08/01/2026 09:43:30 1366925565247755 XLON
32 1304 08/01/2026 09:43:30 1366925565247756 XLON
108 1304 08/01/2026 09:43:30 1366925565247757 XLON
11 1304 08/01/2026 09:43:31 1366925565247758 XLON
66 1310 08/01/2026 09:54:04 1366925565248862 XLON
745 1308 08/01/2026 10:22:57 1366925565251594 XLON
507 1306 08/01/2026 10:23:01 1366925565251612 XLON
304 1306 08/01/2026 10:23:06 1366925565251622 XLON
356 1308 08/01/2026 10:28:24 1366925565252068 XLON
103 1308 08/01/2026 10:28:24 1366925565252073 XLON
8 1308 08/01/2026 10:28:24 1366925565252074 XLON
253 1308 08/01/2026 10:30:46 1366925565252215 XLON
138 1306 08/01/2026 10:35:56 1366925565252647 XLON
468 1312 08/01/2026 11:08:50 1366925565254720 XLON
422 1312 08/01/2026 11:08:50 1366925565254721 XLON
456 1310 08/01/2026 11:17:13 1366925565255297 XLON
512 1310 08/01/2026 11:32:38 1366925565256171 XLON
195 1308 08/01/2026 11:32:50 1366925565256183 XLON
140 1306 08/01/2026 11:37:25 1366925565256357 XLON
3 1304 08/01/2026 11:45:29 1366925565256831 XLON
905 1304 08/01/2026 11:45:29 1366925565256832 XLON
905 1302 08/01/2026 11:47:38 1366925565256965 XLON
592 1302 08/01/2026 11:47:38 1366925565256967 XLON
316 1302 08/01/2026 11:47:38 1366925565256968 XLON
905 1300 08/01/2026 11:49:53 1366925565257082 XLON
899 1300 08/01/2026 11:49:53 1366925565257087 XLON
766 1300 08/01/2026 11:55:17 1366925565257496 XLON
98 1300 08/01/2026 11:55:17 1366925565257497 XLON
71 1298 08/01/2026 11:58:17 1366925565257613 XLON
454 1306 08/01/2026 15:26:45 1366925565288010 XLON
444 1306 08/01/2026 15:26:45 1366925565288013 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSUPURWGUPQPUR
Copyright 2019 Regulatory News Service, all rights reserved